Cormorant Asset Management, LP
Position in MLTX — MoonLake Immunotherapeutics
CIK 1583977
BOSTON, MA
Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,409,780
-$21,105,491 QoQ
Shares Held
3,205,433
-28.5% QoQ
Ownership
3.77%
of shares outstanding
% of Portfolio
3.17%
of 13F equity value
Holder Rank
#5
of 172 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. MLTX ranks #12 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in MLTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,409,780 | 3,205,433 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $83,515,271 | 4,480,433 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,404,606 | 4,355,433 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,298,220 | 1,994,173 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $400,923,927 | 8,494,151 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $331,866,479 | 8,494,151 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $459,958,276 | 8,494,151 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $428,275,093 | 8,494,151 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $373,487,819 | 8,494,151 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $426,661,204 | 8,494,151 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $512,961,778 | 8,494,151 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $464,099,700 | 8,142,100 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $415,247,100 | 8,142,100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $147,422,040 | 6,892,101 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $63,682,510 | 6,065,001 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $47,064,407 | 6,065,001 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,841,255 | 6,065,001 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||